(Total Views: 60)
Posted On: 02/12/2024 8:25:56 AM
Post# of 102129
$SGMO News Article - Sangamo Therapeutics Announces U.S. FDA Alignment on Abbreviated Pathway to Potential Approval and EMA Prime Eligibility for ST-920 in Fabry Disease https://marketwirenews.com/news-releases/sang...90741.html
(0)
(0)
My Twitter: WhyteStocks